chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Vomiting-Medium, Additional Details: it was not a big issue at all. Her daughter was also present to recieve a shot and was also a CNA so she seemed very confident in doing what needed to be done. I contacted her daughter inquiring about Patient and she said he was sleeping. just some vomitting and fainting occurred. after he rehydrated himself he and his daughter left Pharmacy.
Pt. presented to the pharmacy requesting Bivalent vaccine, providing vaccine card.  After administration of vaccination and documentation in the immunization registry it was discovered that a Bivalent vaccine was provided 10/2022.
Spoke with pt on Tuesday 2/3/09 she was administered the HPV vaccine about 4 hours later a rash devloped on her back that grew to cover the majority of her back. She feels that today it is not spreading and she feels it is getting better she dose not tolerate benadryl so that was not advised.  No SOB, pain, fever, hives. Advised pt she should not continue with the HPV series as there is really no way of telling how she may react. She was in agreement with this. Pt will call back if any other symptoms devlope or rash dose not continue to improve over the next few days
sore left arm; fatigue; mild headache; This is a spontaneous report from a contactable consumer, the patient. A 54-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6755) via an unspecified route of administration in the left arm on 23Mar2021 at 10:15 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. Medical history included depression. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was allergic to inderal (MANUFACTURER UNKNOWN), amoxicillin (MANUFACTURER UNKNOWN), erythromycin (MANUFACTURER UNKNOWN) and moxifloxacin (AVELOX). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 01Mar2021 at 10:30, as a single dose for COVID-19 immunisation. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), liraglutide (SAXENDA) and methylphenidate (MANUFACTURER UNKNOWN); all for unknown indication and from an unknown date. The patient also received eletriptan (MANUFACTURER UNKNOWN) for headache from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, patient had not been tested for COVID-19. On 23Mar2021 at 13:00, the patient experienced sore left arm, fatigue and mild headache. It was reported that headache was not likely caused by the vaccine. The patient had long history of headache and recently had headache a week prior to vaccination and took eletriptan. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events pain in arm, fatigue and mild headache was recovered on an unknown date. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Became more ill than any prior vaccine. General mailaise/fatigure, mild fever (unusual for me!), slight temporary nausea, recurring, woke up with fairly violent chills the second night. Symptoms improved up to a point but it is now Tuesday, 9/22 and I'm still feeling fatigue, "foggy brain"/difficulty concentrating for work, lethargy, etc. Not fully recovered and it's been well over 72 hours now.
Triple negative breast cancer; This spontaneous case was reported by a consumer and describes the occurrence of TRIPLE NEGATIVE BREAST CANCER (Triple negative breast cancer) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced TRIPLE NEGATIVE BREAST CANCER (Triple negative breast cancer) (seriousness criterion medically significant). At the time of the report, TRIPLE NEGATIVE BREAST CANCER (Triple negative breast cancer) was resolving.            Concomitant medications were not reported . Treatment information was reported as Chemotherapy and Radiation therapy.  Patient received significant testing including a lumpectomy then started chemotherapy on 8JUL2021. Patient continued to take chemotherapy every weekday up until 16SEP2021. Patient had also started radiation from 19OCT2021 which is scheduled to continue until 16NOV2021. patient was feeling much better now after the conclusion of her chemotherapy. Patient mentioned that her count was really low during her treatments.  This case concerns a 69 year-old female patient with no reported medical history, who experienced the unexpected serious event of triple negative breast cancer. The event occurred approximately 2 months after the second dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a 69 year-old female patient with no reported medical history, who experienced the unexpected serious event of triple negative breast cancer. The event occurred approximately 2 months after the second dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
i received the flu shot at 2:00pm. i was completely healthy at this time.  by 4:00pm i had a 102 temp. and rash.  over next couple days developed extreme headaches and muscle aches in neck. went to ER Thursday morning 9/26/19 and they said it was a reaction from flu shot to take tylenol for next few days. that did not help so i went back to ER Saturday morning 9/28/19. they admitted me and performed CT scan and performed an unsuccessful lumbar puncture at bed side due to doctor could not get needle into right spot. hopsital than started antibiotics for next two days, monday 9/30/19 had successful lumbar puncture that showed Aseptic meningitis. Spent 3 three more days in hopsital and release 10/2/19 late in afternoon
This spontaneous report as received from a physician refers to a 16 years old female patient. The patient was vaccinated with, a 0.5 ml dose of GARDASIL (Lot # not reported) IM. No other co-suspects were reported. No concomitant medications were reported. The physician reported that on 10-JUL-2012, after received an injection of GARDASIL, the patient passed out (medically significant) and fainted in the office. The patient received an unspecified treatment. At the time of the report, the patient's outcome was unknown. Upon internal review passed out was considered as an other important medical event. Additional information has been requested.
PT'S HUSBAND REPORTED THAT PT HAD FEVER, SORENESS IN ALL MUSCLES TO WHERE SHE WAS UNABLE TO MOVE AROUND ALOT AND REDNESS/INFLAMMATION AT INJECTION SITE. STATED THOSE RXNS WERE COMMON- KEEP AN EYE ON THINGS.  THE NEXT DAY- PT CAME IN AND REPORTED THAT THE REDNESS STARTED TO SPREAD AND MUSCLES WERE STILL VERY SORE.  HER FEVER SXS SUBSIDED.  HER ARM WAS VERY RED AND INFLAMED.  IT WAS ALSO WARM TO THE TOUCH.  I RECOMMENDED AND ANTI-INFLAMMATORY AND IF NO IMPROVEMENT IN A DAY- SHE SHOULD SEE MD/GO TO URGENT CARE TO GET LOOKED AT.  ON 11/1/16- PTS HUSBAND CAME INTO PHARMACY AND STATED SHE WENT TO MD AND MD STATED IT WAS CELLULITIS CAUSED FROM GIVING THE INJECTION TO DEEP.
Nausea 3 hours post-injection with mild headache Injection site pain day 1 and 2 post-injection
After receiving the 2nd vaccine on 5/15/21, on 5/16 patient had a "stomach ache", on 5/17 he went to work. At 9:30am, the camera's show him going into the women's restroom to service it, a lady tried to go into the restroom and could not go in, she called the supervisor, when the supervisor arrived there was no pulse. Report source believes he goes into work around 7:00AM.  Report sources states she was told " his blood sugar was not elevated".  Report source states that the death certificate states he had a cardiac arrest.
Mastitis developed 5 days after vaccine given (currently lactating, infant 7 months old; left breast pain and erythema with pustule developing at Montgomery gland the lateral left areola 5 days after vaccine administration with associated, chills, body aches, headaches, nausea, lightheadedness, fatigue worsening at day 6 post vaccine,  antibiotic cephalexin started morning of day 6, feeling better on day 7 with symptoms improving 24 hours post initiation of antibiotic)
Patient received expired vaccines (past manufacture expiration date); Extra dose administered; Inappropriate schedule of vaccine administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccines (past manufacture expiration date)), EXTRA DOSE ADMINISTERED (Extra dose administered) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A, 027A21A and 209K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccines (past manufacture expiration date)), EXTRA DOSE ADMINISTERED (Extra dose administered) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccines (past manufacture expiration date)), EXTRA DOSE ADMINISTERED (Extra dose administered) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.
sublingual glands were swollen and very painful; sublingual glands were swollen and very painful; My parotid glands are a little puffy; This is a spontaneous report received from a contactable consumer or other non hcp.   A 45-year-old male patient received first dose of bnt162b2 (BNT162B2, Batch/lot number: EL9266, expiry date: unknown) via an unspecified route of administration, administered in the region of left Arm on 13Feb2021 at 09:00 as 1st dose, singlefor covid-19 immunisation. Medical history included allergic to penicillin from an unknown date and unknown if ongoing, mint allergy from an unknown date and unknown if ongoing, latex allergy from an unknown date and unknown if ongoing. Concomitant medications included paroxetine taken for an unspecified indication, start and stop date were not reported; bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication, start and stop date were not reported; amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported; acetaminophen (ACETAMINOPHEN) taken for an unspecified indication, start and stop date were not reported.  Other vaccination in four weeks was reported as no. The patient had no covid prior vaccination nor covid tested post vaccination. On 14FEB2021, the patient experienced sublingual glands were swollen and very painful, parotid glands little puffy. Within 24 hours the patient's sublingual glands were swollen and very painful. It had been a couple of days and they were still swollen and painful, making it difficult to eat. It did not appear to be an allergic reaction, and his doctor said he suspects it is vaccine related. The swelling was anywhere between 3-5 mm in depth. The patient's parotid glands were a little puffy as expected, but not painful. Patient did not receive treatment for AE. The outcome of sublingual gland swelling and very painful was not recovered. The outcome of the event parotid glands little puffy was unknown.  No follow up attempts possible. No further information is expected.
Upon waking in the AM, patient had a red rash on the outside of his thigh near the vaccination site.  The rash was made up of round red spots that were brighter red at the edges.  After he had been awake for a while (and skin cooled off?) the rash faded away so I could barely see it anymore.  Daycare called me in the afternoon after his nap when they were changing his diaper, the rash was back, redder than it had been in the AM, and did not fade away.  Also at the Dr office at 4:45pm that day, we found a few more spots of the rash on the opposite leg.  Dr told me not to be concerned, that it looked like hives to him, and that I would probably see the rash come and go and move over his body in the course of the next 3-4 days.  Dr would not confirm if he thought it was a reaction to the vaccines given on 6/8. Dr advised me to give Benadryl if patient seemed uncomfortable/itchy.  Over the next two days, I saw the rash move over his body from legs to arms and torso in smaller red spots - almost like pinprick red spots.  The rash would fade and return. Patient did not seem uncomfortable at all.
Cx give FLUZONE HD and PREVNAR13 both in left arm 1 inch apart on 9/21/15 on 11/4/15. She is still complaining of arm pain when she lifts arm.
Mom reported about 163 chickenpox like spots. No fever noted. Was back to school 5/12/03.
Shortly after the vaccination my left shoulder began having sharp pains if moved in a backward motion. The shoulder continued to have pain and range of motion of the left arm has been significantly reduced due nto sharp pains if I move beyond a certain point.
Information has been received from a licensed practical nurse concerning her 13-year-old white daughter with an allergy to amoxicillin and clavulanic Acid (AUGMENTIN) and azithromycin (ZITHROMAX) who in June 1995, was vaccinated subcutaneous with a first 0.5 ml dose of varicella virus vaccine live (Oka/Merck) and on 25-MAY-2007 (previously reported as in May-2007), the patient received a second subcutaneous 0.5 ml dose of varicella virus vaccine live (Oka/Merck (Lot # 654811/1260F). There was no concomitant therapy. There were no illnesses at the time of vaccination. It was reported that about in early June (7 days after vaccination) the patient experienced flu like symptoms, fatigue, body aches, malaise, low grade fever and a loss of appetite. The symptoms lasted about 3 days and then resolved. The patient was treated with OTC Ibuprofen. At the time of report the patient had recovered. A product quality complaint was not involved. Additional information is not expected.
Shortness of breath, no room air sats measured, came into ER on O2 @3.5lpm sating at 94%  26 Y female who presents with shortness of breath. This is occurring in the context of pre-eclampsia with labor induction at 37 weeks and vaginal delivery.    Patient presents after being discharged from the hospital on 9/29. She has had worsening leg swelling since since returning home, which has progressed beyond her knees. She woke up to breast feed this morning and felt dyspneic. She was unable to catch her breath, prompting her to come to the ED. She endorses pleuritic chest pain. Denies chest pain otherwise. No tearing, ripping back pain. Denies previous history of clot. Denies one leg swelling worse than other leg. Describes mild vaginal discharge with occasional clots. No abdominal pain. No purulent vaginal discharge. No seizures.    She was admitted to the hospital for induction of labor at 37 weeks for pre-eclampsia. She had prolonged labor complicated by chorioamnionitis and sepsis, requiring IV antibiotics. She also required supplemental oxygen via nasal cannula in the hospital but was weaned onto room air before discharge. CT scan negative for PE. Denies history of blood clots.    Has been taking labetalol 100 mg BID at home.
8:50 - c/o dizziness. Diaphoretic. BP 168/92 P 96 RR 16 Blood sugar - 65. Benadryl 50 mg given. Capri Sun given to drink. 9:00 BP 142/74 P 96 RR 16 9:05 142/70 - given animal crackers to eat 9:10 140/72 BS - 78 9:25 138/70 P 80 9:40 140/74 10:15 to Hospital for exam
Patient was nauseated following the injection and continuing to the time of report.  Patient described at the injection site.  Redness and swelling were observed.  Treated for Cellulitis.
redness, swelling, tenderness & rash at injection site starting apprx 1 week after having 1st dose od Moderna.  Rash still visible 15 days after having the vaccine.  ? cellulitis.
Narrative:  COVID infection following COVID vaccine series 03/29, Pfizer, dose #1 04/19, Pfizer, dose #2 12/22 COVID swab, result: detected 12/19 pt cc: cough, fatigue, headache, myalgias, rhinorrhea, exposure: unknown
Cellulitis right arm; red, warm, painful and no fever. Treated with Augmentin 875 bidx10d.
I was fine up until the 5/21. As I was leaving work, I got a horrible headache. I had a fever, coughing, congestion, wheezing, irritated throat--it felt like I had COVID. My lasted from 5/21-5/23. It never got over 100, but I never get fevers. I had a tele-med visit on 5/24 and she had me take antibiotics for a week, but they didn't work. On the 5/28, I spoke with her again and she wanted to see me again in a week. On 6/1, she had me take another round of antibiotics that helped a little, so I was able to return to work part-time. I got a Rocephen injection on 6/7 and that finally helped. I was then able to return to work full time. Currently, I am still experiencing some throat irritation and coughing, but I'm much better. I'm taking some cough medicine that she prescribed as needed.
no adverse event; Vaccine given 1 day beyond BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 1 day beyond BUD) and NO ADVERSE EVENT (no adverse event) in a 57-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7170B) for COVID-19 prophylaxis.     The patient had no known allergies.     On 23-Feb-2023 at 1:30 PM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 23-Feb-2023 at 1:30 AM,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 1 day beyond BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 1 day beyond BUD) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (Vaccine given 1 day beyond BUD) to be related and NO ADVERSE EVENT (no adverse event) to be not related.    No concomitant medications were reported.   Vaccine use by date was reported as 22-Feb-2023.  The event did not cause the patient to seek medical care. There were no other potential causes reported. The patient did not experience similar events in the past.   No treatment details were reported.
Joint range of motion decreased/Could not open/close hand; Unable to walk/Could not walk; Loss of energy/No energy; Paraesthesia hand/Pins and needles feeling in both wrist; Local swelling/Swelling in tendon inside the right ankle; Painful hand/Hands were painful to open in the morning; This spontaneous case was reported by a consumer and describes the occurrence of JOINT RANGE OF MOTION DECREASED (Joint range of motion decreased/Could not open/close hand), GAIT INABILITY (Unable to walk/Could not walk), ASTHENIA (Loss of energy/No energy), PARAESTHESIA (Paraesthesia hand/Pins and needles feeling in both wrist) and SWELLING (Local swelling/Swelling in tendon inside the right ankle) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Rheumatoid arthritis.    No Medical History information was reported.   In 2022, the patient ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced JOINT RANGE OF MOTION DECREASED (Joint range of motion decreased/Could not open/close hand), GAIT INABILITY (Unable to walk/Could not walk), ASTHENIA (Loss of energy/No energy), PARAESTHESIA (Paraesthesia hand/Pins and needles feeling in both wrist), SWELLING (Local swelling/Swelling in tendon inside the right ankle) and PAIN IN EXTREMITY (Painful hand/Hands were painful to open in the morning). At the time of the report, JOINT RANGE OF MOTION DECREASED (Joint range of motion decreased/Could not open/close hand), GAIT INABILITY (Unable to walk/Could not walk), ASTHENIA (Loss of energy/No energy), PARAESTHESIA (Paraesthesia hand/Pins and needles feeling in both wrist), SWELLING (Local swelling/Swelling in tendon inside the right ankle) and PAIN IN EXTREMITY (Painful hand/Hands were painful to open in the morning) outcome was unknown.            This case was identified as part of a retrospective clean-up activity received in the Moderna  were missed to be booked-in.  No concomitant medication was provided.  No treatment medication was provided. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.
First injection 3-20-21.  Left arm sore and trouble raising it for at least one week.  On 3-30-21, I went to hospital for numb left arm and being nauseous. No heart issues, but possible pinched nerve.  Still problems with left arm being numb at times. 2nd injection - Slept for most of 36 hours after injection on 4-26-2021.  On 5-14-21, I discovered a magnet will stay on my arm at the injection site. This was done after talking with co-workers who saw this done on the internet.   During this time, several people also discovered they had a magnetic site.   Is this normal?  And why would my arm be magnetized?  Conspiracy theories are being discussed now.